| 000 | 01204 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517010449.0 | ||
| 264 | 0 | _c20150415 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a0171-2004 | ||
| 024 | 7 |
_a10.1007/978-3-319-09665-0_7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSavolainen, Markku J | |
| 245 | 0 | 0 |
_aEpidemiology: disease associations and modulators of HDL-related biomarkers. _h[electronic resource] |
| 260 |
_bHandbook of experimental pharmacology _c2015 |
||
| 300 |
_a259-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aApolipoproteins _xblood |
| 650 | 0 | 4 |
_aAtherosclerosis _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipoproteins, HDL _xblood |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProtective Factors |
| 650 | 0 | 4 |
_aProteomics _xmethods |
| 650 | 0 | 4 | _aRisk Factors |
| 773 | 0 |
_tHandbook of experimental pharmacology _gvol. 224 _gp. 259-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-319-09665-0_7 _zAvailable from publisher's website |
| 999 |
_c24471563 _d24471563 |
||